Plexus (PLXS)
Nasdaq Market Closed
Plexus Corp is an electronics engineering, manufacturing, and product lifecycle services company that works with customers whose products require high reliability, technical precision, and strict quality controls. Rather than focusing on high-volume consumer electronics, Plexus specialises in complex products used in regulated and mission-critical markets, including healthcare and life sciences, aerospace and defence, industrial applications, and semiconductor capital equipment.
The company supports customers from early product design through manufacturing and after-market services. Its capabilities include design and development, supply chain management, new product introduction, production, testing, fulfilment, and sustaining services. This integrated model allows customers to outsource important parts of the product lifecycle while retaining access to specialised engineering and manufacturing expertise.
Plexus is particularly positioned in markets where failure can carry significant cost or safety implications. Its work can involve life-supporting or life-enhancing medical technologies, aerospace and defence systems, factory automation equipment, and tools used in semiconductor production. These end markets typically demand documentation, traceability, quality assurance, and regulatory discipline, creating barriers to entry for less specialised manufacturers.
The company reports operations across the Americas, Asia-Pacific, and Europe, the Middle East and Africa, with Asia-Pacific representing a major revenue contributor. Its global footprint helps customers manage production close to key supply chains and end markets, while also spreading operational capacity across regions.
For investors, Plexus represents exposure to outsourced electronics manufacturing with a focus on complexity rather than scale alone. Its performance is shaped by customer programme wins, product ramps, supply chain conditions, demand in industrial and healthcare markets, defence spending trends, and capital equipment cycles in the semiconductor industry.
Last updated
- Market Cap
- 7.55B
- P/E
- 40.28
- P/FCF
- 99.65
- P/S
- 1.75
- Enterprise Value
- 7.48B
- Sector
- Information Technology
- Industry
- Printed Circuit Boards
- Address
- PLEXUS CORP, NEENAH, WI, 54956
Pixalate Releases Global Top 25 Most Popular Connected TV (CTV) FAST Apps Reports for Q1 2025: ‘Sling TV’ No. 1 on Roku, 'Plex' Leads on Apple TV and Samsung Smart TV
Plexus to Present at the Raymond James 46th Annual Institutional Investors Conference
Plexus Issues Fiscal 2023 Sustainability Report
Why Is Plexus (PLXS) Up 12.4% Since Last Earnings Report?
Plexus to Present at the 2024 Stifel Cross Sector Insight Conference
Plexus (PLXS) Q2 Earnings & Revenues Beat Estimates, Fall Y/Y
Plexus (PLXS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Plexus Announces Fiscal Second Quarter Financial Results
Plexus (PLXS) to Report Q2 Earnings: Key Factors to Note
Plexus Sets Fiscal Second Quarter 2024 Earnings Release Date
Plexus (PLXS) Up 0.3% Since Last Earnings Report: Can It Continue?
Plexus to Present at the Raymond James 45th Annual Institutional Investors Conference
Plexus (PLXS) Q1 Earnings & Revenues Miss Estimates, Fall Y/Y
Plexus (PLXS) Reports Q1 Earnings: What Key Metrics Have to Say
Plexus Announces Fiscal First Quarter Financial Results
Unveiling Plexus (PLXS) Q1 Outlook: Wall Street Estimates for Key Metrics
Plexus Announces Preliminary Fiscal First Quarter 2024 Results and Additional Share Repurchase Program
Plexus Provides Update on Unverified List Removal
Plexus Provides Update on Unverified List Designation
Plexus Joins the United Nations Global Compact
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 7.55B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 7.48B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 40.28
- P/B
P/B ratio compares a company's share price to its book value per share.
- 5.07
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 1.75
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 24.92
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.74
- EPS
- 7.01
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 99.65
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 43.92
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 75.79M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 12.59%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 5.58%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.16
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.54
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.74
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.18
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 318.27K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 282.29
Income Statement
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Revenue | 1.16B | 1.07B | 1.06B | 1.02B | 980.17M |
| Gross profit | 119.18M | 106.14M | 104.78M | 103.29M | 97.75M |
| Operating income | 61.84M | 54.46M | 53.11M | 53.61M | 48.79M |
| EBITDA | 81.09M | 73.7M | 72.4M | 73.19M | 68.31M |
| Net income | 49.81M | 41.18M | 51.43M | 45.12M | 39.07M |
| Basic EPS | 1.86 | 1.54 | 1.91 | 1.67 | 1.44 |
| Diluted EPS | 1.82 | 1.51 | 1.87 | 1.64 | 1.41 |
Balance Sheet
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Total assets | 3.36B | 3.19B | 3.14B | 3.11B | 3.09B |
| Total liabilities | 1.87B | 1.7B | 1.68B | 1.69B | 1.73B |
| Total equity | 1.49B | 1.48B | 1.45B | 1.42B | 1.35B |
| Cash & equivalents | 303.13M | 248.83M | 306.46M | 237.57M | 310.53M |
| Current assets | 2.64B | 2.46B | 2.4B | 2.4B | 2.4B |
| Current liabilities | 1.71B | 1.54B | 1.52B | 1.52B | 1.57B |
Cash Flow
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Operating cash flow | 28.46M | -15.38M | 132.02M | 26.88M | 36.69M |
| Investing cash flow | -12.55M | -35.13M | -34.76M | -14.1M | -20.27M |
| Financing cash flow | 37.77M | -7.99M | -28.12M | -90.19M | -25.33M |
| Change in cash | 53.76M | -57.34M | 69.14M | -72.95M | -7.29M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 144 — PLEXUS CORP | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| form 4 | Form 4 — Kelsey Todd P. | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| form 4 | Form 4 — Rapp Karen Marie | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| edgar index | SD — PLEXUS CORP | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| form 4 | Form 4 — Kelsey Todd P. | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| form 4 | Form 4 — Kelsey Todd P. | View Filing | |
| form 4 | Form 4 — Kelsey Todd P. | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| edgar index | 3 — PLEXUS CORP | View Filing | |
| form 3 | Form 3 — Abuhl David Westen | View Filing | |
| form 3 | Form 3 — Abuhl David Westen | View Filing | |
| form 3 | Form 3 — Abuhl David Westen | View Filing | |
| form 3 | Form 3 — Abuhl David Westen | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| form 4 | Form 4 — Tan Victor (Pang Hau) | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| form 4 | Form 4 — Ninivaggi Angelo Michael Jr | View Filing | |
| form 4 | Form 4 — Ninivaggi Angelo Michael Jr | View Filing | |
| form 4 | Form 4 — Ninivaggi Angelo Michael Jr | View Filing | |
| edgar index | 10-Q — PLEXUS CORP | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| form 4 | Form 4 — Ninivaggi Angelo Michael Jr | View Filing | |
| form 4 | Form 4 — Ninivaggi Angelo Michael Jr | View Filing | |
| form 4 | Form 4 — Ninivaggi Angelo Michael Jr | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| form 4 | Form 4 — Kelsey Todd P. | View Filing | |
| form 4 | Form 4 — Jermain Patrick John | View Filing | |
| form 4 | Form 4 — Jermain Patrick John | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| form 4 | Form 4 — Kelsey Todd P. | View Filing | |
| form 4 | Form 4 — Kelsey Todd P. | View Filing | |
| form 4 | Form 4 — Kelsey Todd P. | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| form 4 | Form 4 — Kelsey Todd P. | View Filing | |
| form 4 | Form 4 — Kelsey Todd P. | View Filing | |
| edgar index | 8-K — PLEXUS CORP | View Filing | |
| edgar index | SCHEDULE 13G — PLEXUS CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| form 4 | Form 4 — Kelsey Todd P. | View Filing | |
| edgar index | SCHEDULE 13G/A — PLEXUS CORP | View Filing | |
| edgar index | SCHEDULE 13G/A — PLEXUS CORP | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| form 4 | Form 4 — Kelsey Todd P. | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| form 4 | Form 4 — Rapp Karen Marie | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| form 4 | Form 4 — MARTINEZ RANDY J | View Filing | |
| form 4 | Form 4 — Running Michael J. | View Filing | |
| edgar index | 8-K — PLEXUS CORP | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| edgar index | 4 — PLEXUS CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing | |
| edgar index | 144 — PLEXUS CORP | View Filing |